O-08 Alteration of the Sexual Response Cycle in Women Using Combined Oral Contraceptives

Abstract

Sexual health is of fundamental importance in maintaining the stability of affective relationships; it is considered as one of the factors that help the emergence, recovery and maintenance of well-being and overall good health of the individual. The cycle of human sexual response is a physiological model of four phases, in order of occurrence they are: excitation phase, plateau phase, orgasm phase and resolution phase. Female sexual disorders involve an extensive multifactorial relationship, and it encompasses four main disorders: orgasmic, sexual arousal, sexual desire and pain. A controlled clinical trial was conducted in 174 women between 18 and 39 years of age who underwent two hormonal contraceptive options with estradiol Valerate / Dienogest and Ethinylestradiol / Drospirenone, attended at the clinic La Sagrada Familia, Armenia, Quindío, between March 2013 and March 2017. The randomization method was simple, women were divided into two groups, pairs (A) and odd (B) groups, with group A treated with estradiol Valerate / Dienogest, and group B with Ethinylestradiol / Drospirenone. After informed consent of the patients, the sexual function was evaluated through the IFSF, initially, at six months, at 18 months and 36 months until the end of the study.